In search of a catalytic bioscavenger for the prophylaxis of nerve agent toxicity

Chemico-Biological Interactions

Volumn 187, Issue 1-3, 2010, Pages 349-354

  diTargiani, Robert C ^a   Chandrasekaran, Lakshmi ^a   Belinskaya, Tatyana ^a   Saxena, Ashima ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

Bioscavenger; Catalytic; OP poisoning; PON1; Prolidase; SMP 30; Stoichiometric

Indexed keywords

BACTERIAL ENZYME; CYCLOSARIN; ORGANOPHOSPHORUS COMPOUND; RECOMBINANT ARYLDIALKYLPHOSPHATASE; RECOMBINANT ENZYME; RECOMBINANT PROLINE DIPEPTIDASE; RECOMBINANT REGUCALCIN; SARIN; SCAVENGER; SOMAN; TABUN; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME ISOLATION; ENZYME STRUCTURE; ESCHERICHIA COLI; HYDROLYSIS; PROTEIN EXPRESSION; SCAVENGING SYSTEM; SITE DIRECTED MUTAGENESIS;

BACTERIA (MICROORGANISMS); CAPRA HIRCUS; MAMMALIA;

EID: 77955511057     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2010.02.021     Document Type: Article

References (37)

1. Gray A.P. Design and structure-activity relationships of antidotes to organophosphorus anticholinesterase agents. Drug Metab. Rev. 1984, 15(3):557-589.
2. Bajgar J., Jakl A., Hrdina V. Effect of atropine and trimedoxime on the acetylcholinesterase activity in some parts of the mouse brain. Cesk. Farm. 1971, 20(7):257-260.
3. Mesulam M.M., Guillozet A., Shaw P., Levey A., Duysen E.G., Lockridge O. Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine. Neuroscience 2002, 110(4):627-639.
4. Dirnhuber P., French M.C., Green D.M., Leadbeater L., Stratton J.A. The protection of primates against soman poisoning by pretreatment with pyridostigmine. J. Pharm. Pharmacol. 1979, 31(5):295-299.
5. Saxena A., Luo C., Chilukuri N., Maxwell D.M., Doctor B.P. Novel approaches to medical protection against chemical warfare nerve agents. Chemical Warfare Agents Chemistry, Pharmacology, and Therapeutics 2007, 145-173. CRC Press, Boca Raton, FL. J.A.J. Romano, B.J. Lukey, H. Salem (Eds.).
6. Lenz D.E., Yeung D., Smith J.R., Sweeney R.E., Lumley L.A., Cerasoli D.M. Stoichiometric and catalytic scavengers as protection against nerve agent toxicity: a mini review. Toxicology 2007, 233(1-3):31-39.
7. Lupi A., Tenni R., Rossi A., Cetta G., Forlino A. Human prolidase and prolidase deficiency: an overview on the characterization of the enzyme involved in proline recycling and on the effects of its mutations. Amino Acids 2008, 35(4):739-752.
8. Cheng T.C., Harvey S.P., Chen G.L. Cloning and expression of a gene encoding a bacterial enzyme for decontamination of organophosphorus nerve agents and nucleotide sequence of the enzyme. Appl. Environ. Microbiol. 1996, 62(5):1636-1641.
9. Besio R., Alleva S., Forlino A., Lupi A., Meneghini C., Minicozzi V., Profumo A., Stellato F., Tenni R., Morante S. Identifying the structure of the active sites of human recombinant prolidase. Eur. Biophys. J. 2009.
10. Furlong C.E., Richter R.J., Chapline C., Crabb J.W. Purification of rabbit and human serum paraoxonase. Biochemistry 1991, 30(42):10133-10140.
11. Billecke S., Draganov D., Counsell R., Stetson P., Watson C., Hsu C., La Du B.N. Human serum paraoxonase (PON1) isozymes Q and R hydrolyze lactones and cyclic carbonate esters. Drug Metab. Dispos. 2000, 28(11):1335-1342.
12. Harel M., Aharoni A., Gaidukov L., Brumshtein B., Khersonsky O., Meged R., Dvir H., Ravelli R.B., McCarthy A., Toker L., Silman I., Sussman J.L., Tawfik D.S. Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes. Nat. Struct. Mol. Biol. 2004, 11(5):412-419.
13. Little J.S., Broomfield C.A., Fox-Talbot M.K., Boucher L.J., MacIver B., Lenz D.E. Partial characterization of an enzyme that hydrolyzes sarin, soman, tabun, and diisopropyl phosphorofluoridate (DFP). Biochem. Pharmacol. 1989, 38(1):23-29.
14. Kondo Y., Inai Y., Sato Y., Handa S., Kubo S., Shimokado K., Goto S., Nishikimi M., Maruyama N., Ishigami A. Senescence marker protein 30 functions as gluconolactonase in l-ascorbic acid biosynthesis, and its knockout mice are prone to scurvy. Proc. Natl. Acad. Sci. U.S.A. 2006, 103(15):5723-5728.
15. Fujita T. Senescence marker protein-30 (SMP30): structure and biological function. Biochem. Biophys. Res. Commun. 1999, 254(1):1-4.
16. Kondo Y., Ishigami A., Kubo S., Handa S., Gomi K., Hirokawa K., Kajiyama N., Chiba T., Shimokado K., Maruyama N. Senescence marker protein-30 is a unique enzyme that hydrolyzes diisopropyl phosphorofluoridate in the liver. FEBS Lett. 2004, 570(1-3):57-62.
17. Wang S.H., Liu M., Chi M.G., Wang Q.D., Sun M.J. Production of human liver prolidase by Saccharomyces cerevisiae as host cells. Acta Pharmacol. Sin. 2004, 25(6):794-800.
18. Wang S.H., Zhi Q.W., Sun M.J. Purification and characterization of recombinant human liver prolidase expressed in Saccharomyces cerevisiae. Arch. Toxicol. 2005, 79(5):253-259.
19. Davies H.G., Richter R.J., Keifer M., Broomfield C.A., Sowalla J., Furlong C.E. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin. Nat. Genet. 1996, 14(3):334-336.
20. Cheng T.C., Harvey S.P., Stroup A.N. Purification and properties of a highly active organophosphorus acid anhydrolase from Alteromonas undina. Appl. Environ. Microbiol. 1993, 59(9):3138-3140.
21. Dumas D.P., Durst H.D., Landis W.G., Raushel F.M., Wild J.R. Inactivation of organophosphorus nerve agents by the phosphotriesterase from Pseudomonas diminuta. Arch. Biochem. Biophys. 1990, 277(1):155-159.
22. Amitai G., Gaidukov L., Adani R., Yishay S., Yacov G., Kushnir M., Teitlboim S., Lindenbaum M., Bel P., Khersonsky O., Tawfik D.S., Meshulam H. Enhanced stereoselective hydrolysis of toxic organophosphates by directly evolved variants of mammalian serum paraoxonase. FEBS J. 2006, 273(9):1906-1919.
23. De la Hoz D., Doctor B.P., Ralston J.S., Rush R.S., Wolfe A.D. A simplified procedure for the purification of large quantities of fetal bovine serum acetylcholinesterase. Life Sci. 1986, 39(3):195-199.
24. L. Chandrasekaran, N. Dosanjh, A. Saxena, R. diTargiani, Expression and characterization of recombinant human prolidase and its metalloforms, in preparation.
25. Billecke S.S., Primo-Parmo S.L., Dunlop C.S., Doorn J.A., La Du B.N., Broomfield C.A. Characterization of a soluble mouse liver enzyme capable of hydrolyzing diisopropyl phosphorofluoridate. Chem. Biol. Interact. 1999, 119-120:251-256.
26. Myara I., Charpentier C., Lemonnier A. Optimal conditions for prolidase assay by proline colorimetric determination: application to iminodipeptiduria. Clin. Chim. Acta 1982, 125(2):193-205.
27. Gan K.N., Smolen A., Eckerson H.W., La Du B.N. Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities. Drug Metab. Dispos. 1991, 19(1):100-106.
28. Ellman G.L., Courtney K.D., Andres V., Feather-Stone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961, 7:88-95.
29. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227(5259):680-685.
30. Ashani Y., Leader H., Rothschild N., Dosoretz C. Combined effect of organophosphorus hydrolase and oxime on the reactivation rate of diethylphosphoryl-acetylcholinesterase conjugates. Biochem. Pharmacol. 1998, 55(2):159-168.
31. DeFrank J.J., Beaudry W.T., Cheng T.C., Harvey S.P., Stroup A.N., Szafraniec L.L. Screening of halophilic bacteria and Alteromonas species for organophosphorus hydrolyzing enzyme activity. Chem. Biol. Interact. 1993, 87(1-3):141-148.
32. Scharff E.I., Koepke J., Fritzsch G., Lucke C., Ruterjans H. Crystal structure of diisopropylfluorophosphatase from Loligo vulgaris. Structure 2001, 9(6):493-502.
33. Otto T.C., Kasten S.A., Kovaleva E., Liu Z., Buchman G., Tolosa M., Davis D., Smith J.R., Balcerzak R., Lenz D.E., Cerasoli D.M. Purification and characterization of functional human paraoxonase-1 expressed in Trichoplusia ni Larvae. Chem. Biol. Interact. 2010, 187:388-392.
34. Rochu D., Chabriere E., Masson P. Human paraoxonase: a promising approach for pre-treatment and therapy of organophosphorus poisoning. Toxicology 2007, 233(1-3):47-59.
35. Cheng T.C., DeFrank J.J. Wide-range Application of Alteromonas prolidase For Decontamination of G-type Chemical Nerve Agents 2000, CBMTS III, Spiez, Switzerland.
36. Yeung D.T., Smith J.R., Sweeney R.E., Lenz D.E., Cerasoli D.M. Direct detection of stereospecific soman hydrolysis by wild-type human serum paraoxonase. FEBS J. 2007, 274(5):1183-1191.
37. Aharoni A., Gaidukov L., Khersonsky O., Mc Q.G.S., Roodveldt C., Tawfik D.S. The 'evolvability' of promiscuous protein functions. Nat. Genet. 2005, 37(1):73-76.